Our news

  • Plain language conclusions:It may be safe to stop antihypertensive medications in older people who are taking the medication for high blood pressure or primary prevention of heart diseaseOlder adults should not stop any of their medications with out talking to a healthcare professionalFuture studies should include older adults who are taking...
    June 12 2020
  • Introducing the Cochrane Circulation & Breathing NetworkWatch the video: https://buff.ly/2XlwLJEThis network covers the work of  Cochrane Hypertension, Cochrane Airways, Cochrane Heart, Cochrane Stroke, and Cochrane Vascular
    July 8 2019
  • Conclusions:Blood pressure-lowering therapy in people with hypertension 60 years and older reduced death, strokes, and heart attacksBenefit was similar if both upper and lower blood pressure numbers were elevated and if only the upper number was elevatedFirst-line treatment used in most studies was a thiazideMagnitude of benefit in cardiovascular...
    July 8 2019
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Winter 2020) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter...
    February 28 2019
  • First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertensionCompared to first-line renin angiotensin system (RAS inhibitors), first-line thiazides reduce heart failure (HF) and strokeCompared with calcium channel blockers (CCBs), RAS inhibitors reduce HF, but increase stroke; the...
    November 14 2018
  • 18thSeptember 2018Authors’ response to Dr. Swapnil Hiremath’s critical remarks on our recently updated Cochrane systematic review Luis Carlos Saiz1, Javier Gorricho2, Javier Garjón3, Mª Concepción Celaya3, Juan Erviti1, Leire Leache11 Unit of Innovation and Organization, Navarre Health Service, Pamplona, Spain.2 Planning, Evaluation...
    September 3 2018
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Autumn 2018) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter...
    July 24 2018
  • No net health benefit derived from a lower blood pressure targetThe Cochrane Hypertension Group updated their original 2017 Cochrane Review to determine if 'lower' blood pressure targets (equal to or below 135/85 mmHg) are associated with a reduction in mortality and morbidity compared to standard (equal to or below 140/85 mmHg) targets...
    July 20 2018
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our fifth newsletter (Spring 2018) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter topics...
    April 23 2018
  • Thiazides best first choice for hypertensionHigh blood pressure or hypertension can increase the risk of heart attacks and stroke. One of the most important decisions in treating people with elevated blood pressure is what drug class to use first. This decision has important consequences in terms of health outcomes and cost.The Cochrane...
    April 20 2018

Pages

Subscribe to Our news